Exercise and Breast Cancer During COVID-19 Pandemic

The effect of 16 weeks of concurrent home-based exercise on some physiological, psychological, functional, and anthropometric indices in females with breast cancer during the COVID-19 pandemic

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210617051606N4

Enrollment

Registered

2021-11-21

Start date

2021-11-26

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: This group performs home-based concurrent training including body-weight resistance training and step aerobic 2 times per week for 16 weeks. The training program co

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Diagnosed with breast cancer by a specialist No signs of relapse or tumor metastasis No less than 3 months and more than 5 years passed from the last cancer-specific treatment (chemotherapy or radiotherapy) Not participating in regular exercise training within last 6 months

Exclusion criteria

Exclusion criteria: Cardiovascular and pulmonary diseases Alcohol and other kinds of drug addiction Musculoskeletal disorder Pregnancy Refusal to give informed consent

Design outcomes

Primary

Measure	Time frame
Change in serum levels of Cortisol. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of blood sample and ELISA method.;Change in quality of life. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: Cancer quality of life questionnaire (EORTC-QOQ-C30).;Changes in cancer-related fatigue. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of Functional Assessment of Chronic Illness Therapy- Fatigue Scale (Version 4).	—

Measure

Time frame

Change in serum levels of Cortisol. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of blood sample and ELISA method.;Change in quality of life. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: Cancer quality of life questionnaire (EORTC-QOQ-C30).;Changes in cancer-related fatigue. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of Functional Assessment of Chronic Illness Therapy- Fatigue Scale (Version 4).

—

Secondary

Measure	Time frame
Changes in body image. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of standard cancer-specific 10-item body image scale.;Changes in cardiovascular endurance. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of sub-maximal 1-mile (1600 m) walking Rockport test.;Changes in body composition. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of bioelectrical impedance analysis.;Changes in cognitive function. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of Cognitive Failure Questionnaire (25 items).	—

Measure

Time frame

Changes in body image. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of standard cancer-specific 10-item body image scale.;Changes in cardiovascular endurance. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of sub-maximal 1-mile (1600 m) walking Rockport test.;Changes in body composition. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of bioelectrical impedance analysis.;Changes in cognitive function. Timepoint: Before starting the intervention, and 16 weeks after starting the intervention. Method of measurement: By the use of Cognitive Failure Questionnaire (25 items).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Amiri

Razi University

e.amiri@razi.ac.ir+98 83 3845 8428

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026